Drugs / AlloGen-LI
last change Sep 2017 re-read 9 days ago

AlloGen-LI

Other / unclassified

Investigated by
University of Southern California · VIVEX Biologics, Inc.

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02932020 Oct 2016 → Sep 2017 — University of Southern California Withdrawn No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AlloGen-LI ClinicalTrials.gov intervention name — accepted as the source's own label NCT02932020 ↗
Modality Other / unclassified “an allograft derived from amniotic fluid” NCT02932020 ↗
Route Other “injected into the epidural space” NCT02932020 ↗